Dose Management Injection Devices
|出版商||Greystone Research Associates||商品編碼||320239|
Greystone Research Associates is pleased to announce the publication of a new market study. Dose Management Injection Devices: Markets, Players, Strategies and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector.
The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, participants and commercial opportunities for injection devices that incorporate dose management features to assist patients in self-managing their drug administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
For self-administration, compliance with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. Autoinjectors are designed to address the patient compliance issue by making the delivery of injectable drugs less complicated and intimidating. Efforts to enhance compliance have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. For chronic conditions compliance has a direct effect on the patient's quality-of-life. Injectable devices with Dose management features address the natural desire of patients for simplicity, and encourage enhanced compliance and appropriate behavior. Dose management features that are increasingly being integrated into injection devices include dose memory, dose time stamping, selectable cartridge concentration, and audible prompts. Markets include OEM devices and aftermarket add-on dose reminders.